These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 24689340)

  • 1. Myeloma stem cell concepts, heterogeneity and plasticity of multiple myeloma.
    Kotouček PP; Orfao A
    Br J Haematol; 2014 Aug; 166(3):466-7. PubMed ID: 24689340
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypoxia promotes stem cell-like phenotype in multiple myeloma cells.
    Muz B; de la Puente P; Azab F; Luderer M; Azab AK
    Blood Cancer J; 2014 Dec; 4(12):e262. PubMed ID: 25479569
    [No Abstract]   [Full Text] [Related]  

  • 3. Stem cell marker nestin is expressed in plasma cells of multiple myeloma patients.
    Svachova H; Pour L; Sana J; Kovarova L; Raja KR; Hajek R
    Leuk Res; 2011 Aug; 35(8):1008-13. PubMed ID: 21440298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiogenic activity of mesenchymal stem cells in multiple myeloma.
    Wang X; Zhang Z; Yao C
    Cancer Invest; 2011 Jan; 29(1):37-41. PubMed ID: 21166497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of interleukin 16 in multiple myeloma.
    Atanackovic D; Hildebrandt Y; Templin J; Cao Y; Keller C; Panse J; Meyer S; Reinhard H; Bartels K; Lajmi N; Sezer O; Zander AR; Marx AH; Uhlig R; Zustin J; Bokemeyer C; Kröger N
    J Natl Cancer Inst; 2012 Jul; 104(13):1005-20. PubMed ID: 22745469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response to "CD20 positive cells are undetectable in the majority of multiple myeloma cell lines and are not associated with a cancer stem cell phenotype". Haematologica 2012;97(7):1110-4.
    Van Hoef ME
    Haematologica; 2013 Jan; 98(1):e11. PubMed ID: 23277593
    [No Abstract]   [Full Text] [Related]  

  • 7. Reply to “Response to “CD20 positive cells are undetectable in the majority of multiple myeloma cell lines and are not associated with a cancer stem cell phenotype”. Haematologica 2012;97(7):1110-1114.
    Paíno T; Paiva B; San Miguel J
    Haematologica; 2013 Jan; 98(1):e10. PubMed ID: 23397607
    [No Abstract]   [Full Text] [Related]  

  • 8. Advances in immunotherapy of multiple myeloma: from the discovery of tumor-associated antigens to clinical trials.
    Chiriva-Internati M; Cobos E; Kast WM
    Int Rev Immunol; 2007; 26(3-4):197-222. PubMed ID: 17558744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Myeloma stem/progenitor cells as new targets for therapy of multiple myeloma--review].
    Ma YL; Hou J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec; 16(6):1459-64. PubMed ID: 19099665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single-chain Fv diabody against human leukocyte antigen-A molecules specifically induces myeloma cell death in the bone marrow environment.
    Sekimoto E; Ozaki S; Ohshima T; Shibata H; Hashimoto T; Abe M; Kimura N; Hattori K; Kawai S; Kinoshita Y; Yamada-Okabe H; Tsuchiya M; Matsumoto T
    Cancer Res; 2007 Feb; 67(3):1184-92. PubMed ID: 17283154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A serum-free culture method for myeloma progenitors in vitro: proliferative and immunophenotypic characteristics.
    Rhodes EG; Olive C; Flynn MP
    Exp Hematol; 1990 Feb; 18(2):79-83. PubMed ID: 2406157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility of malignant plasma cells to HA-1(H) specific lysis suggests a role for the minor histocompatibility antigen HA-1 in the graft-versus-myeloma effect.
    Holloway PA; Kaldenhoven N; van Dijk M; Bloem AC; de Lau W; van der Zee R; Kircher-Eibl B; Mutis T; Lokhorst HM
    Leukemia; 2004 Sep; 18(9):1543-5. PubMed ID: 15322561
    [No Abstract]   [Full Text] [Related]  

  • 13. Morphological polysome analysis and surface expression of human myeloma cells: presence of heterogeneity.
    Yonezawa T; Katagiri S
    Nihon Ketsueki Gakkai Zasshi; 1986 Dec; 49(8):1766-73. PubMed ID: 3551441
    [No Abstract]   [Full Text] [Related]  

  • 14. Elimination of chemoresistant myeloma clonogenic cells from human bone marrow by monoclonal antibody and complement.
    Tong AW; Dalton WS; Tsuruo T; Fay JW; Stone MJ
    Prog Clin Biol Res; 1990; 333():155-64. PubMed ID: 2308979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonotypic myeloma cells able to xenograft myeloma to nonobese diabetic severe combined immunodeficient mice copurify with CD34 (+) hematopoietic progenitors.
    Pilarski LM; Belch AR
    Clin Cancer Res; 2002 Oct; 8(10):3198-204. PubMed ID: 12374689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD52 expression patterns in myeloma and the applicability of alemtuzumab therapy.
    Rawstron AC; Laycock-Brown G; Hale G; Davies FE; Morgan GJ; Child JA; Hillmen P; Owen RG
    Haematologica; 2006 Nov; 91(11):1577-8. PubMed ID: 17043027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Identification of myeloma-initiating cells and development of their targeting therapy].
    Hosen N; Sugiyama H
    Rinsho Ketsueki; 2013 Jun; 54(6):505-12. PubMed ID: 23823088
    [No Abstract]   [Full Text] [Related]  

  • 18. Elimination of chemoresistant multiple myeloma clonogenic colony-forming cells by combined treatment with a plasma cell-reactive monoclonal antibody and a P-glycoprotein-reactive monoclonal antibody.
    Tong AW; Lee J; Wang RM; Dalton WS; Tsuruo T; Fay JW; Stone MJ
    Cancer Res; 1989 Sep; 49(17):4829-34. PubMed ID: 2569359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induced expression of B7-1 on myeloma cells following retroviral gene transfer results in tumor-specific recognition by cytotoxic T cells.
    Tarte K; Zhang XG; Legouffe E; Hertog C; Mehtali M; Rossi JF; Klein B
    J Immunol; 1999 Jul; 163(1):514-24. PubMed ID: 10384156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using genomics to identify high-risk myeloma after autologous stem cell transplantation.
    Shaughnessy JD; Barlogie B
    Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 1):77-80. PubMed ID: 16399589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.